Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
M-type potassium channels are low-threshold, non-inactivating voltage-gated ion channels that play a fundamental role in regulating neuronal excitability throughout the central and peripheral nervous systems [1, 5]. They are primarily composed of heterotetramers of KCNQ2 and KCNQ3 subunits (also known as Kv7.2 and Kv7.3), although KCNQ4 and KCNQ5 can also contribute to the M-current [3, 10]. These channels are unique for being open at subthreshold membrane potentials, where they provide a stabilizing outward potassium current that acts as a "brake" on repetitive action potential firing and prevents hyperexcitability [8, 12]. The activity of M-channels is tightly regulated by various signaling molecules, most notably phosphatidylinositol 4,5-bisphosphate (PIP2) and muscarinic acetylcholine receptors, the latter of which inhibit the channel to increase neuronal responsiveness [4, 12]. Dysfunction or mutations in the genes encoding these subunits are directly linked to several forms of epilepsy, including benign familial neonatal convulsions (BFNC) [3, 9]. Consequently, M-type channels are significant therapeutic targets; pharmacological activators like retigabine have been developed to treat seizures and are being investigated for conditions such as chronic pain and tinnitus [6, 7, 10].
Positive allosteric modulation of KCNQ2-5 subunits to increase channel open probability and hyperpolarize the membrane potential; or inhibition via pore blockade or muscarinic receptor-mediated depletion of PIP2.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on M-type potassium channel (M-channel).